68 related articles for article (PubMed ID: 8829911)
1. [Why is there no sustained-release form of captopril?].
Thürmann P; Rietbrock N
Dtsch Med Wochenschr; 1996 Aug; 121(34-35):1072. PubMed ID: 8829911
[No Abstract] [Full Text] [Related]
2. [Sublingual captopril: indications and advantages?].
Meyer GJ
Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S4. PubMed ID: 10818992
[No Abstract] [Full Text] [Related]
3. [Neutropenia induced by low doses of captopril in hypertensive patients without associated autoimmune disease].
Ortega G; Molina M; Rivera MD; Serrano C
An Med Interna; 1999 Aug; 16(8):436. PubMed ID: 10507176
[No Abstract] [Full Text] [Related]
4. [New options against undertreatment].
Pfeffer M
MMW Fortschr Med; 2003 Dec; 145(49):18. PubMed ID: 14963987
[No Abstract] [Full Text] [Related]
5. Determination of captopril by high-performance liquid chromatography with direct electrogenerated chemiluminescence.
Sun Y; Zhang Z; Zhang X
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Mar; 105():171-5. PubMed ID: 23299024
[TBL] [Abstract][Full Text] [Related]
6. In vitro-in vivo correlation and bioavailability studies of captopril from novel controlled release donut shaped tablet.
Mandal AS; Chatterjee S; Kundu S; Biswas N; Guha A; Paul S; Kuotsu K
Int J Pharm; 2011 Dec; 421(1):145-50. PubMed ID: 21945741
[TBL] [Abstract][Full Text] [Related]
7. CAPPP trial. Captopril Prevention Project.
Lim PO
Lancet; 1999 May; 353(9166):1793; author reply 1795-6. PubMed ID: 10348009
[No Abstract] [Full Text] [Related]
8. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
9. The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
Kramkowski K; Mogielnicki A; Chabielska E; Cylwik D; Buczko W
Thromb Res; 2006; 117(5):557-61. PubMed ID: 15985287
[No Abstract] [Full Text] [Related]
10. [New discoveries on target blood pressure and ACE inhibitors. Swedish guidelines on hypertension are still correct].
Ostergren J
Lakartidningen; 1998 Aug; 95(32-33):3380-1. PubMed ID: 9725941
[No Abstract] [Full Text] [Related]
11. [Evaluation of the evenness of the antihypertensive effect of losartan and captopril by using a 24-hour monitoring of arterial pressure].
Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
Ter Arkh; 2001; 73(2):38-43. PubMed ID: 11338852
[TBL] [Abstract][Full Text] [Related]
12. Captopril reduces portal pressure effectively in portal hypertensive patients with low portal venous velocity.
Baik SK; Park DH; Kim MY; Choi YJ; Kim HS; Lee DK; Kwon SO; Kim YJ; Park JW; Chang SJ
J Gastroenterol; 2003; 38(12):1150-4. PubMed ID: 14714252
[TBL] [Abstract][Full Text] [Related]
13. HPLC determination of captopril in human plasma and its pharmacokinetic study.
Li K; Tan L; Zhou JA
Biomed Chromatogr; 1996; 10(5):237-9. PubMed ID: 8879531
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in sustained/controlled oral delivery of captopril: an overview.
Nur AO; Zhang JS
Int J Pharm; 2000 Jan; 194(2):139-46. PubMed ID: 10692638
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of antiproteinuric effect by combined therapy with angiotensin II receptor blocker plus calcium channel blocker in a hypertensive patient with IgA glomerulonephritis.
Kuriyama S; Tomonari H; Abe A; Kunieda T; Hosoya T
J Hum Hypertens; 2002 May; 16(5):371-3. PubMed ID: 12082501
[No Abstract] [Full Text] [Related]
16. The effect of valsartan and captopril on lipid parameters in patients with type II diabetes mellitus and nephropathy.
Cheung R; Lewanczuk RZ; Rodger NW; Huff MW; Oddou-Stock P; Botteri F; Pecher E; Muirhead N
Int J Clin Pract; 1999 Dec; 53(8):584-92. PubMed ID: 10692751
[TBL] [Abstract][Full Text] [Related]
17. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous determination of captopril and hydrochlorothiazide in human plasma by reverse-phase HPLC from linear gradient elution.
Huang T; He Z; Yang B; Shao L; Zheng X; Duan G
J Pharm Biomed Anal; 2006 May; 41(2):644-8. PubMed ID: 16413728
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
Rosei EA; Rizzoni D;
J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic modelling for captopril in healthy anaesthetized piglets.
Pereira CM; Tam YK; Coe JY; Olley PM; Collins-Nakai RL
Biopharm Drug Dispos; 1996 Jul; 17(5):365-72. PubMed ID: 8830975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
